Form D · Biotechnology
Zymeworks Inc.
Vancouver, A1 · CIK 0001403752
Offering snapshot reported Jan 21, 2016 · SEC filing
- Reported sold
- $61.5M Offering amount: $75M
- Investors reported
- 15 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jan 7, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 21, 2016 | Initial | $61,517,859 | No comparison | 15 | SEC filing |
| Feb 27, 2015 | Initial | $1,785,700 | No comparison | 1 | SEC filing |
| Jan 20, 2015 | Amendment | $23,988,700 | -$3,011,300vs Nov 4, 2014 | 1 | SEC filing |
| Jan 8, 2015 | Initial | $8,601,260 | No comparison | 1 | SEC filing |
| Nov 4, 2014 | Initial | $27,000,000 | No comparison | 1 | SEC filing |
| Apr 21, 2014 | Amendment | $1,025,752 | $76,464vs Feb 14, 2014 | 3 | SEC filing |
| Feb 14, 2014 | Amendment | $949,288 | $929,288vs Dec 17, 2013 | 2 | SEC filing |
| Dec 17, 2013 | Initial | $20,000 | No comparison | 1 | SEC filing |
| Aug 22, 2012 | Initial | $10,853,700 | No comparison | 31 | SEC filing |
| Oct 27, 2011 | Initial | $7,092,463 | No comparison | 25 | SEC filing |
| Jul 2, 2009 | Initial | $451,847 | No comparison | 9 | SEC filing |
| Jun 14, 2007 | Paper | Not reported | No comparison | Not reported |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $2.1M
- Finders' fees
- $0 (estimated)
- Form D file number
- 021-255657
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| BMO CAPITAL MARKETS CORP. | 16686 | |
| MTS SECURITIES LLC | 104059 |
Source: Form D, filed Jan 21, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Nick Bedford | Director |
| Surjit Dixit | Executive |
| Donald Drakeman | Director |
| Haig Farris | Director |
| Kenneth Galbraith | Director |
| Noel Hall | Director |
| Ian Ihnatowycz | Director |
| Neil Klompas | Executive |
| Dion Madsen | Director |
| Patrick Mc Croskey | Director |
| Amos Michelson | Director |
| Amos Michelson | Director |
| Gordon Ng | Executive |
| Ali Tehrani | Director, Executive |
| Shermaine Tilley | Director |
| David Tucker | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
540 1385 West 8 Th Avenue
Vancouver, A1, V6H 3V9
Vancouver, A1, V6H 3V9